Growth Metrics

Pacira BioSciences (PCRX) Short-Term Debt issuances (2021 - 2023)

Pacira BioSciences has reported Short-Term Debt issuances over the past 3 years, most recently at -$149.5 million for Q4 2023.

  • For Q4 2023, Short-Term Debt issuances changed N/A year-over-year to -$149.5 million; the TTM value through Sep 2024 reached -$149.5 million, changed N/A, while the annual FY2025 figure was $101.0 million, N/A changed from the prior year.
  • Short-Term Debt issuances for Q4 2023 was -$149.5 million at Pacira BioSciences, down from $149.6 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $363.8 million in Q4 2021 and troughed at -$149.5 million in Q4 2023.